Triodos Investment Management Bv Edwards Lifesciences Corp Transaction History

Triodos Investment Management Bv

$1.3 Billion
Q2 2025

A detailed history of Triodos Investment Management Bv transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Triodos Investment Management Bv holds 509,258 shares of EW stock, worth $39.9 Million. This represents 3.05% of its overall portfolio holdings.

Number of Shares

509,258

Previous 507,758 0.3%

Holding current value

$39.9 Million

Previous $36.8 Million 8.23%

% of portfolio

3.05%

Previous 3.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$67.07 - $78.22 $100,604 - $117,330	1,500 Added 0.3%	509,258 $39.8 Million
Q1 2025 May 14, 2025	SELL	$67.95 - $76.19 $149,490 - $167,618	-2,200 Reduced 0.43%	507,758 $36.8 Million
Q4 2024 Feb 12, 2025	BUY	$64.54 - $75.92 $45,178 - $53,144	700 Added 0.14%	509,958 $37.8 Million
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $6.05 Million - $9.5 Million	101,300 Added 24.83%	509,258 $33.6 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $2.88 Million - $3.79 Million	39,700 Added 10.78%	407,958 $39 Million
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $370,260 - $466,560	-6,000 Reduced 1.6%	368,258 $28.1 Million
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $1.16 Million - $1.56 Million	-16,742 Reduced 4.28%	374,258 $25.9 Million
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $223,877 - $259,407	-2,750 Reduced 0.7%	391,000 $36.9 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $371,300 - $422,550	-5,000 Reduced 1.25%	393,750 $32.6 Million
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $4.17 Million - $5.34 Million	-61,100 Reduced 13.29%	398,750 $29.8 Million
Q3 2022 Nov 09, 2022	BUY	$82.37 - $107.29 $4.06 Million - $5.29 Million	49,300 Added 12.01%	459,850 $38 Million
Q2 2022 Aug 08, 2022	BUY	$86.5 - $128.27 $64,875 - $96,202	750 Added 0.18%	410,550 $39 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $1.4 Million - $1.72 Million	13,200 Added 3.33%	409,800 $53.1 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $720,370 - $859,250	-7,000 Reduced 1.73%	396,600 $44.9 Million
Q2 2021 Jul 20, 2021	BUY	$83.84 - $104.76 $100,608 - $125,712	1,200 Added 0.3%	403,600 $41.8 Million
Q1 2021 May 11, 2021	BUY	$78.68 - $90.67 $2.2 Million - $2.54 Million	28,000 Added 7.48%	402,400 $33.7 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $1.04 Million - $1.32 Million	14,500 Added 4.03%	374,400 $34.2 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $5.2 Million - $6.77 Million	77,400 Added 27.4%	359,900 $28.7 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $10.2 Million - $13.7 Million	177,400 Added 168.79%	282,500 $19.5 Million
Q1 2020 May 04, 2020	BUY	$52.41 - $81.0 $1.27 Million - $1.97 Million	24,300 Added 30.07%	105,100 $19.8 Million
Q4 2019 Feb 04, 2020	SELL	$71.7 - $82.09 $43,020 - $49,254	-600 Reduced 0.74%	80,800 $18.9 Million
Q3 2019 Nov 05, 2019	SELL	$61.55 - $75.43 $1.76 Million - $2.16 Million	-28,600 Reduced 26.0%	81,400 $17.9 Million
Q2 2019 Jul 30, 2019	SELL	$55.74 - $64.41 $496,086 - $573,249	-8,900 Reduced 7.49%	110,000 $20.3 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $541,157 - $723,765	-11,300 Reduced 8.68%	118,900 $22.7 Million
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $1.68 Million - $2.07 Million	-36,300 Reduced 21.8%	130,200 $19.9 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $388,450 - $493,255	-8,500 Reduced 4.86%	166,500 $29 Million
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $7.43 Million - $8.98 Million	175,000 New	175,000 $25.5 Million

Others Institutions Holding EW

# of Institutions

1,403

Shares Held

484M

Call Options Held

3.12M

Put Options Held

1.83M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $48.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triodos Investment Management Bv, based on Form 13F filings with the SEC.

News

Stay updated on Triodos Investment Management Bv with notifications on news.

Account

Triodos Investment Management Bv Edwards Lifesciences Corp Transaction History